JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB36810

Anti-ATM (phospho S1981) antibody [10H11.E12]

5

(2 Reviews)

|

(92 Publications)

Mouse Monoclonal ATM phospho S1981 antibody. Suitable for IHC-P, Flow Cyt (Intra), WB and reacts with Human samples. Cited in 92 publications.

View Alternative Names

Serine-protein kinase ATM, Ataxia telangiectasia mutated, A-T mutated, ATM

6 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)

ab36810 staining human colon tissue. Staining is localized to the nucleus.
Left panel : with primary antibody at 4 μg/ml. Right panel : Isotype control.
Sections were stained using an automated system DAKO Autostainer Plus at room temperature. Sections were rehydrated and antigen retrieved with the DAKO 3-in-1 antigen retrieval buffer citrate pH 6.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with hematoxylin and coverslipped under DePeX.

Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Flow Cytometry (Intracellular) - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)

Overlay histogram showing HeLa cells stained with ab36810 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab36810, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)
  • WB

Unknown

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)

Lysate loading concentration : 40µg

All lanes:

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (ab36810) at 1/1000 dilution

Lane 1:

Control lane

Lane 2:

Irradiated Human fibroblasts (10 Gy gamma-irradiation)

Lane 3:

Molecular weight marker

Lane 4:

Peroxidated Human fibroblasts (300 µM hydrogen peroxide)

Lane 5:

Peroxidated Human fibroblasts (1 mM hydrogen peroxide)

Lane 6:

Peroxidated Human fibroblasts (10 mM hydrogen peroxide)

Predicted band size: 351 kDa

Observed band size: 370 kDa

true

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)
  • WB

Unknown

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)

All lanes:

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (ab36810) at 10 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg

Lane 2:

Extract from patient with Ataxia-Telangiectasia whole cell lysate at 20 µg

Lane 3:

Irradiated HeLa Whole Cell Lysate at 20 µg

Secondary

All lanes:

Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 351 kDa

Observed band size: 100 kDa,110 kDa,145 kDa,200 kDa,370 kDa

true

Exposure time: 20min

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)
  • WB

CiteAb

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)

Western Blotting using Anti-ATM (phospho S1981) antibody [10H11.E12], ab36810. Publication image from Gueven, N. et al., 2010, Mol Cancer, 20663147. Legend direct from paper.

p63 depletion attenuates ATM expression and ATM-dependent phosphorylation. (A) pSUPER-p63 RNAi attenuates ATM mRNA levels. HaCat cells were transfected with 1 µg pSUPER-CON or pSUPER-p63si vectors, and selected for geneticin resistance for 4 days. mRNA was extracted from surviving cells and real-time RT-PCR was used to quantitate changes in ATM mRNA expression. Data is represented as fold-change over empty vector control. (B) pSUPER-p63si inhibits ATM expression and p53 Serine-15 phosphorylation in HaCat cells. pSUPER-CON or pSUPER-p63si transfected HaCat cells were harvested after selection for 48 and 96 hours, and immunoblotted for the indicated proteins. (C) pSUPER-p63 RNAi inhibits HaCat cell proliferation. HaCaT cells were transfected with pSUPER-CON or pSUPER-p63si vectors, selected for geneticin resistance for 14 days, and surviving colonies were giemsa stained and counted. (D) siRNA-mediated p63 depletion attenuates ATM mRNA expression. HaCat cells untreated (NT) or treated with control siRNA or p63-targeted siRNA were harvested after 24 hrs or 48hrs and analysed by real-time RT-PCR for p63 and ATM mRNA expression. Data is normalised to β-actin and represented as fold-change over mRNA level in cells treated with control siRNA in particular time point. The data represent the average of three independent experiments + SD. The symbol asterisk denotes significant difference with p values < 0.05 determined by Mann-Whitney test, from the cells treated with control siRNA.

false

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)
  • WB

CiteAb

Western blot - Anti-ATM (phospho S1981) antibody [10H11.E12] (AB36810)

Western Blotting using Anti-ATM (phospho S1981) antibody [10H11.E12], ab36810. Publication image from Gueven, N. et al., 2010, Mol Cancer, 20663147. Legend direct from paper.

The ATM pathway is active in HaCaT cells. (A) Damage-induced p53 Serine-15 is mediated by ATM. HaCat cells were treated with DMSO carrier, 10 µM KU-55933 (ATM inhibitor) or 1 µM NU7441 (DNA-PK inhibitor) for 2 hours, then with 0.5 µM doxorubicin, and cells were harvested after 2hrs, or cells were treated with 20Jm2 UV radiation and harvested after 6hrs. Lysates were blotted for phosphoSerine-15 p53, phosphoSerine-392 p53, total p53 protein and p63, as indicated. (B) ATM inhibition blocks constitutive p53 Serine-15 phosphorylation. Cells were treated with DMSO carrier, 10 µM KU-55933 (ATM inhibitor) or 1 µM NU7441 (DNA-PK inhibitor) for 24 hrs, and lysates were immunoblotted for phosphoSerine-15 p53 and total p53 protein. (C) ATM inhibition blocks constitutive ATM-dependent phosphorylation. Cells were treated with DMSO carrier or 10 µM KU-55933 for 24 hrs, and lysates were immunoblotted for : phosphoSerine-15 p53, phosphoSerine-392 p53, total p53 protein, phosphoThreonine-68 Chk2, total Chk2 protein, phosphoSerine-1891 ATM, and total ATM protein. (D) siRNA-mediated ATM depletion blocks p53 Serine-15 phosphorylation. HaCat cells were treated with control siRNA or siRNA to ATM for 24, 48 or 96hrs, and cell lysates were blotted for ATM, phosphoSerine-15 p53, and total p53 protein.

false

  • Carrier free

    Anti-ATM (phospho S1981) antibody [10H11.E12] - BSA and Azide free

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

10H11.E12

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

IHC-P, Flow Cyt (Intra), WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "6 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1 µg for 10^5 Cells", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>Abcam recommends using 3% Milk as the blocking agent.</p>" } } }

Product details

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 6.97% L-Arginine
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ATM also known as Ataxia Telangiectasia Mutated is a protein kinase with a molecular weight of approximately 370 kDa. ATM protein primarily resides in the cell nucleus and functions as a critical regulator of the cell cycle. It plays a significant role in the detection of DNA damage and initiation of repair processes. As part of its mechanical functions ATM phosphorylates serine and threonine residues on various substrates most notably in response to double-strand breaks in DNA. This activity is important for maintaining genomic stability.
Biological function summary

ATM acts as a coordinator in cellular response to DNA damage highly interacting with multiple components of the DNA repair machinery. It forms a complex with proteins like NBS1 and MRN complex facilitating repair by recruiting and activating other proteins involved in homologous recombination and non-homologous end joining pathways. ATM also modulates p53 activity a primary response factor in cellular stress management linking ATM to control of cell cycle arrest and apoptosis. This positions ATM as an integral part of maintaining cellular integrity in face of genomic insult.

Pathways

ATM integrates neatly within the DNA damage response and cell cycle control pathways. ATM's operative relationship with the MRN complex and its role in the PI3K-related protein kinase family helps initiate appropriate repair processes upon DNA damage detection. Additionally ATM regulates the activity of proteins such as Chk2 which further propagates signals to p53 influencing decisions between cell cycle arrest and apoptosis. These interactions link ATM closely to essential processes like DNA repair and cell survival highlighting its role in genomic maintenance.

ATM mutations or dysregulation leads to Ataxia Telangiectasia an autosomal recessive disorder characterized by neurodegeneration immune deficiencies and cancer predisposition. ATM dysfunction also connects to cancer development particularly breast cancer where it transmits signals involving BRCA1 contributing to DNA repair through homologous recombination. Understanding ATM dynamics and related pathways has important implications for developing therapeutic strategies to manage or mitigate effects associated with its dysfunction.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor (PubMed : 10550055, PubMed : 10839545, PubMed : 10910365, PubMed : 12556884, PubMed : 14871926, PubMed : 15064416, PubMed : 15448695, PubMed : 15456891, PubMed : 15790808, PubMed : 15916964, PubMed : 17923702, PubMed : 21757780, PubMed : 24534091, PubMed : 35076389, PubMed : 9733514). Recognizes the substrate consensus sequence [ST]-Q (PubMed : 10550055, PubMed : 10839545, PubMed : 10910365, PubMed : 12556884, PubMed : 14871926, PubMed : 15448695, PubMed : 15456891, PubMed : 15916964, PubMed : 17923702, PubMed : 24534091, PubMed : 9733514). Phosphorylates 'Ser-139' of histone variant H2AX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism (By similarity). Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FBXW7, FANCD2, NFKBIA, BRCA1, CREBBP/CBP, RBBP8/CTIP, FBXO46, MRE11, nibrin (NBN), RAD50, RAD17, PELI1, TERF1, UFL1, RAD9, UBQLN4 and DCLRE1C (PubMed : 10550055, PubMed : 10766245, PubMed : 10802669, PubMed : 10839545, PubMed : 10910365, PubMed : 10973490, PubMed : 11375976, PubMed : 12086603, PubMed : 15456891, PubMed : 19965871, PubMed : 21757780, PubMed : 24534091, PubMed : 26240375, PubMed : 26774286, PubMed : 30171069, PubMed : 30612738, PubMed : 30886146, PubMed : 30952868, PubMed : 38128537, PubMed : 9733515, PubMed : 9843217). May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation (PubMed : 19965871). Phosphorylates ATF2 which stimulates its function in DNA damage response (PubMed : 15916964). Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (PubMed : 29203878). Phosphorylates TTC5/STRAP at 'Ser-203' in the cytoplasm in response to DNA damage, which promotes TTC5/STRAP nuclear localization (PubMed : 15448695). Also involved in pexophagy by mediating phosphorylation of PEX5 : translocated to peroxisomes in response to reactive oxygen species (ROS), and catalyzes phosphorylation of PEX5, promoting PEX5 ubiquitination and induction of pexophagy (PubMed : 26344566).
See full target information ATM pS1981

Publications (92)

Recent publications for all applications. Explore the full list and refine your search

Science advances 11:eado7660 PubMed40238889

2025

Nuclear accumulation of YTHDF1 regulates mRNA splicing in the DNA damage response.

Applications

Unspecified application

Species

Unspecified reactive species

Jingyu Hou,Yunyi Gao,Bing Han,Sujun Yan,Saisai Wei,Xiangwei Gao

MedComm 5:e548 PubMed38645664

2024

Mechanism of Musashi2 affecting radiosensitivity of lung cancer by modulating DNA damage repair.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjin Qu,Xiong Shi,Ying Xu,Hongran Qin,Junshi Li,Shanlin Cai,Jianpeng Zhao,Bingbing Wan,Yanyong Yang,Bailong Li

Acta pharmacologica Sinica 45:1276-1286 PubMed38438580

2024

Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yin-da Qiu,Qi Yan,Yi Wang,Yan-Fei Ye,Yan Wang,Meng-Ying Wang,Pei-Pei Wang,Shu-Yuan Zhang,Da-Long Wang,Hao Yan,Jing Ruan,Yun-Jie Zhao,Le-Hao Huang,Namki Cho,Kun Wang,Xiao-Hui Zheng,Zhi-Guo Liu

Scientific reports 13:15171 PubMed37704669

2023

The fructose-bisphosphate, Aldolase A (ALDOA), facilitates DNA-PKcs and ATM kinase activity to regulate DNA double-strand break repair.

Applications

Unspecified application

Species

Unspecified reactive species

Thais Sobanski,Amila Suraweera,Joshua T Burgess,Iain Richard,Chee Man Cheong,Keyur Dave,Maddison Rose,Mark N Adams,Kenneth J O'Byrne,Derek J Richard,Emma Bolderson

Science advances 9:eadf2860 PubMed37390209

2023

Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness.

Applications

Unspecified application

Species

Unspecified reactive species

Elena Oropeza,Sinem Seker,Sabrina Carrel,Aloran Mazumder,Daniel Lozano,Athena Jimenez,Sabrina N VandenHeuvel,Dillon A Noltensmeyer,Nindo B Punturi,Jonathan T Lei,Bora Lim,Susan E Waltz,Shreya A Raghavan,Matthew N Bainbridge,Svasti Haricharan

Cells 12: PubMed37296639

2023

The Impact of NAD Bioavailability on DNA Double-Strand Break Repair Capacity in Human Dermal Fibroblasts after Ionizing Radiation.

Applications

Unspecified application

Species

Unspecified reactive species

Maria Svetlova,Ljudmila Solovjeva,Andrey Kropotov,Andrey Nikiforov

International journal of molecular sciences 24: PubMed37239999

2023

Nuclear DJ-1 Regulates DNA Damage Repair via the Regulation of PARP1 Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Zhong-Xuan Wang,Yi Liu,Yao-Lin Li,Qiao Wei,Rong-Rong Lin,Ruiqing Kang,Yang Ruan,Zhi-Hao Lin,Nai-Jia Xue,Bao-Rong Zhang,Jia-Li Pu

International journal of molecular sciences 24: PubMed37108069

2023

Interaction between Cigarette Smoke and Human Papillomavirus 16 E6/E7 Oncoproteins to Induce SOD2 Expression and DNA Damage in Head and Neck Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Diego Carrillo-Beltrán,Julio C Osorio,Rancés Blanco,Carolina Oliva,Enrique Boccardo,Francisco Aguayo

Biology direct 17:40 PubMed36476259

2022

Alpha-actnin-4 (ACTN4) selectively affects the DNA double-strand breaks repair in non-small lung carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Daria Kriger,Ksenia Novitskaya,Giomar Vasileva,Ekaterina Lomert,Nikolai D Aksenov,Nikolai A Barlev,Dmitri Tentler

Cancer research 82:4571-4585 PubMed36353752

2022

ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Massimiliano Mellone,Klaudia Piotrowska,Giulia Venturi,Lija James,Aleksandra Bzura,Maria A Lopez,Sonya James,Chuan Wang,Matthew J Ellis,Christopher J Hanley,Josephine F Buckingham,Kerry L Cox,Gareth Hughes,Viia Valge-Archer,Emma V King,Stephen A Beers,Vincent Jaquet,George D D Jones,Natalia Savelyeva,Emre Sayan,Jason L Parsons,Stephen Durant,Gareth J Thomas
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com